BALTIMORE--(BUSINESS WIRE)--Cerecor Inc. (NASDAQ:CERC), a clinical-stage biopharmaceutical company developing treatments to make a difference in the lives of patients with neurological and psychiatric disorders, today announced that it will present at the BIO CEO & Investor Conference taking place February 8-9, 2016, at the Waldorf Astoria in New York City. Dr. Uli Hacksell, CEO, President and Chairman of Cerecor, is scheduled to present at 3 p.m. EST, Monday, February 8, 2016.
